Literature DB >> 6667250

Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan.

N Kobayashi, T Maekawa, M Takada, H Tanaka, H Gonmori.   

Abstract

From analysis of the clinical and laboratory findings in the DIC patients collected by JRDC, diagnostic criteria for the diagnosis of DIC are proposed. The characteristics of the criteria are as follows: (1) a scoring system is adopted; (2) as the tests for scoring, PT, plasma Fbg level, serum FDP level, and platelet count are used; (3) different scores are given according to the grade of change in the results of the tests; (4) bleeding and clinical signs indicating organ dysfunction due to DIC are included in the scoring system; and (5) recognition of the well-known etiological factors of DIC is also scored.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667250     DOI: 10.1159/000408467

Source DB:  PubMed          Journal:  Bibl Haematol        ISSN: 0067-7957


  66 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Supportive care for hemostatic complications associated with pediatric leukemia: a national survey in Japan.

Authors:  Shinya Osone; Keitaro Fukushima; Michihiro Yano; Mariko Kakazu; Hirozumi Sano; Yoko Kato; Yuichi Shinkoda; Kunihiro Shinoda; Naoko Mori; Souichi Adachi
Journal:  Int J Hematol       Date:  2019-09-26       Impact factor: 2.490

3.  Association between necropsy evidence of disseminated intravascular coagulation and coagulation variables before death in patients in intensive care units.

Authors:  J T Wilde; K M Roberts; M Greaves; F E Preston
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

4.  Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.

Authors:  Kunimoto Ichikawa; Yoko Edahiro; Akihiko Gotoh; Kazuhide Iiduka; Norio Komatsu; Michiaki Koike
Journal:  Int J Hematol       Date:  2016-07-25       Impact factor: 2.490

5.  D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis.

Authors:  Fabrizio Semeraro; Concetta T Ammollo; Pietro Caironi; Serge Masson; Roberto Latini; Mauro Panigada; Antonio Pesenti; Nicola Semeraro; Luciano Gattinoni; Mario Colucci
Journal:  Blood Transfus       Date:  2019-11-19       Impact factor: 3.443

6.  Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH.

Authors:  Tzu-Fei Wang; Robert S Makar; Darko Antic; Jerrold H Levy; James D Douketis; Jean M Connors; Marc Carrier; Jeffrey I Zwicker
Journal:  J Thromb Haemost       Date:  2020-12       Impact factor: 5.824

7.  Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.

Authors:  Hideki Uchiumi; Takafumi Matsushima; Arito Yamane; Noriko Doki; Hiroyuki Irisawa; Takayuki Saitoh; Tohru Sakura; Takahiro Jimbo; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

8.  Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.

Authors:  T Iba; Y Yagi; A Kidokoro; M Fukunaga; T Fukunaga
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.

Authors:  Takumi Aota; Hideo Wada; Yoshiki Yamashita; Takeshi Matsumoto; Kohshi Ohishi; Kei Suzuki; Hiroshi Imai; Masanobu Usui; Shuji Isaji; Naoyuki Katayama
Journal:  Int J Hematol       Date:  2015-11-21       Impact factor: 2.490

10.  A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation.

Authors:  Nobuo Aoki; Tamotsu Matsuda; Hidehiko Saito; Kiyoshi Takatsuki; Kenji Okajima; Hoyu Takahashi; Junki Takamatsu; Hidesaku Asakura; Nobuya Ogawa
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.